Stroke Recovery Treatment
Stroke recovery treatment does not have to end at six months. Most stroke survivors are told the first six months are all that matter, and that whatever function hasn’t returned by then probably won’t. That claim does not hold up against the neuroscience. Neuroplasticity does not shut off on a schedule. At The Neurogenesis Project, we target the metabolic, inflammatory, and cellular barriers that keep viable brain tissue from recovering, regardless of how long ago the stroke occurred.
Available at our St. Marys, Georgia clinic.
The Recovery Plateau Is Not a Biological Law
The conventional timeline for stroke recovery is built around a clinical observation, not a biological rule. Most spontaneous recovery happens in the first three to six months after a stroke because that is when the brain’s acute repair mechanisms are most active—edema resolves, collateral blood flow develops, and perilesional neurons begin to compensate for lost circuitry. When that initial burst of improvement tapers off, patients and clinicians often interpret the slowdown as a permanent ceiling.
The evidence says otherwise. Cramer (2008, published in Annals of Neurology) outlined the molecular and cellular mechanisms of brain repair after stroke, emphasizing that the biological capacity for reorganization persists well beyond the acute recovery window. Murphy and Corbett (2009, published in Nature Reviews Neuroscience) demonstrated that plasticity mechanisms in peri-infarct cortex—the tissue surrounding the stroke core—remain active for months and can be enhanced with targeted intervention. More recent work by Bhatt et al. (2015) has shown functional gains in chronic stroke patients using brain stimulation protocols, confirming that the substrate for improvement does not disappear simply because time has passed.
The problem is not that the brain stops trying to recover. The problem is that the conditions driving the plateau—chronic neuroinflammation, mitochondrial dysfunction in surviving neurons, and inadequate trophic support—are rarely addressed by standard rehabilitation. Physical therapy and occupational therapy train motor patterns and compensatory strategies. They do not change the metabolic environment that determines whether damaged neurons can respond to that training.
Peri-Infarct Tissue: The Biological Opportunity
When a stroke occurs, the tissue at the center of the infarct dies rapidly from complete loss of blood flow. But surrounding that core is a region called the ischemic penumbra—tissue that received enough collateral perfusion to survive but not enough to function normally. In the acute phase, saving this penumbral tissue is the primary goal of thrombolysis and thrombectomy. In the chronic phase, this same region represents the most promising target for recovery.
Peri-infarct neurons are not dead. Many are metabolically compromised—running on depleted mitochondrial reserves, bathed in low-grade inflammatory mediators, and cut off from the trophic signals they need to reintegrate into functional circuits. They exist in a state that neuroscientists sometimes call “idling”—alive but not contributing. The question is whether the right intervention can shift them from idling back to working.
Standard rehabilitation does not target this tissue directly. It works at the behavioral level, asking intact circuits to compensate for lost ones through repetitive practice. That approach produces meaningful gains in the acute and subacute windows, but it hits a ceiling once the easy compensatory pathways have been recruited. Breaking through that ceiling requires addressing what is happening at the cellular level in the tissue that standard rehab cannot reach.
Our Treatment Protocol for Stroke Recovery
Each protocol is assembled based on the patient’s diagnostic findings. These are the therapies we draw from most frequently in post-stroke cases.
Exosome Therapy
Extracellular vesicles that cross the blood-brain barrier and deliver anti-inflammatory cytokines, neurotrophic factors, and regulatory microRNAs to peri-infarct tissue. Preclinical stroke models have shown reduced infarct volume and improved functional outcomes with MSC-derived exosomes.
Stem Cell Therapy
Mesenchymal stem cells exert paracrine effects on peri-infarct tissue—releasing trophic factors that promote angiogenesis, modulate the local immune response, and support axonal sprouting. These cells do not replace dead neurons but create conditions that allow surviving tissue to reintegrate into functional networks.
NAD+ IV Therapy
Nicotinamide adenine dinucleotide is the central coenzyme in mitochondrial energy production. Neurons in the peri-infarct zone operate under severe metabolic stress. IV NAD+ provides the substrate these mitochondria need to restore ATP output and reduce the reactive oxygen species that drive ongoing cellular damage.
NeuroCoaching
Dr. Drew Edwards provides ongoing behavioral coaching that helps stroke survivors adapt daily routines, build cognitive strategies, and sustain the gains made during the intensive program. Recovery does not end when the infusions stop—NeuroCoaching bridges the gap between clinical treatment and long-term functional improvement.
Diagnostics That Guide Treatment
A structural MRI shows where the infarct is. It does not tell you what the tissue around it is doing. That distinction matters because the peri-infarct zone is where treatment has the most to offer, and its metabolic state varies enormously from patient to patient.
We use advanced neuroimaging to map metabolic activity in the brain and identify regions of hypometabolism—areas that are alive but operating well below capacity. These metabolic cold spots frequently correspond to the functional deficits patients describe: the cognitive slowing, the word-finding difficulty, the motor imprecision that persists long after the acute event.
Inflammatory biomarker panels and metabolic labs complete the picture. Chronic neuroinflammation is a well-documented barrier to post-stroke plasticity. We measure the specific cytokines, oxidative stress markers, and metabolic indicators that tell us whether the systemic environment is supporting or inhibiting the brain’s recovery efforts. Learn more about our imaging approach on our brain imaging page.
Related Treatments
Exosome Therapy
Extracellular vesicles that cross the blood-brain barrier and deliver anti-inflammatory signals, growth factors, and regulatory microRNAs to damaged neural tissue.
Stem Cell Therapy
Mesenchymal stem cells modulate the post-injury immune response, support angiogenesis, and release neurotrophic factors that promote tissue repair in the peri-infarct zone.
What to Expect
Stroke history and deficit assessment
Estimated time: 30 minutes
Dr. Orr reviews the details of your stroke including type, location, timing, acute treatment received, and current residual deficits. He evaluates motor function, speech, cognition, mood, and how the stroke has affected your daily life.
Neurological examination
Estimated time: 30 minutes
A comprehensive exam quantifies your current neurological deficits across motor, sensory, language, cognitive, and coordination domains. Dr. Orr uses standardized scales to establish a baseline for tracking recovery.
Imaging and vascular risk assessment
Estimated time: 30 minutes
Dr. Orr reviews existing imaging and may order updated brain MRI, carotid Doppler, or MRA to evaluate the stroke territory, collateral circulation, and ongoing vascular risk. Blood work assesses modifiable risk factors.
Neurorecovery treatment protocol
Estimated time: 30 minutes
Treatment may include IV therapies to support neural repair, stem cell or exosome therapy for regenerative support, and coordination with physical, occupational, and speech therapy. The protocol targets your specific deficits.
Recovery monitoring and secondary prevention
Estimated time: 20 minutes
Dr. Orr schedules follow-up assessments to track recovery, adjusts treatments based on progress, and manages secondary stroke prevention including vascular risk factor optimization.
Frequently Asked Questions
How long after a stroke can treatment still help?+
There is no hard cutoff. The brain can make gains years after a stroke. We have treated patients more than a decade after their stroke who still showed measurable improvement.
Read the full answer
There is no hard cutoff. The idea that meaningful recovery ends at six months is not supported by the current neuroscience literature. Studies have demonstrated neuroplastic changes and functional improvement years after stroke onset. We have treated patients whose strokes occurred more than a decade ago and who still showed measurable gains on cognitive and motor assessments. The window for recovery depends on the individual’s injury pattern, the viability of surrounding tissue, and the metabolic and inflammatory environment in the brain—not an arbitrary calendar date.
What makes your approach different from standard stroke rehabilitation?+
Standard rehab focuses on repetitive exercise and task practice. We add regenerative therapies and metabolic support to improve the brain's biological environment so it can respond more effectively to rehabilitation.
Read the full answer
Standard stroke rehab focuses primarily on repetitive task practice—physical therapy, occupational therapy, speech therapy. These are valuable and we support their continued use. But they address the behavioral output without treating the underlying metabolic and inflammatory conditions in the brain that limit recovery. We layer regenerative therapies like exosome and stem cell treatment, and metabolic support with NAD+ infusions on top of the rehabilitation work the patient is already doing. The goal is to improve the biological environment so the brain can respond more effectively to therapy.
What diagnostic testing do you perform for stroke patients?+
We use advanced neuroimaging to assess the tissue around the stroke and inflammatory and metabolic blood panels to understand what is driving or blocking recovery.
Read the full answer
We use advanced neuroimaging to assess the metabolic status of peri-infarct tissue—the area surrounding the stroke core that is often compromised but not dead. Quantitative EEG maps cortical activity patterns and identifies regions where reorganization is occurring or could be facilitated. We also run inflammatory biomarker panels and metabolic labs to understand the systemic environment driving or inhibiting recovery. These diagnostics allow us to target treatment at viable tissue rather than applying a generic protocol.
Is this program appropriate for someone who had a stroke years ago?+
Yes. Many of our patients come years after their stroke because their initial rehab gains plateaued. The tissue around an old stroke is often still metabolically active but operating under stress that treatment can address.
Read the full answer
Yes. Many of our stroke patients present years after their event, often because their initial rehabilitation gains plateaued and no one offered a next step. The peri-infarct tissue surrounding an old stroke is frequently still metabolically active but operating under chronic inflammatory and metabolic stress. Our protocols are designed to address exactly that state. We evaluate each patient individually and are straightforward about what we expect treatment to achieve given their specific situation.
How is the treatment delivered?+
The initial program runs three to five days at our St. Marys, Georgia clinic. It includes diagnostic testing, review with Dr. Orr, IV therapies, and NeuroCoaching, with optional follow-up cycles.
Read the full answer
Our Intensive Brain Health Program is typically delivered over three to five consecutive days in our St. Marys, Georgia clinic. Patients receive diagnostic testing, a detailed review of findings with Dr. Orr, and a full course of IV-based and regenerative therapies during that window. NeuroCoaching with Dr. Edwards provides ongoing behavioral support after the initial visit. Some patients return for follow-up infusion cycles at intervals determined by their clinical response.
Does insurance cover post-stroke treatment at your clinic?+
We operate outside insurance networks but provide superbills for out-of-network reimbursement. Our patient coordinator can discuss costs and payment options before you schedule.
Read the full answer
The Neurogenesis Project operates outside of insurance networks. Our diagnostic and treatment protocols use therapies that are not typically covered by commercial insurance plans or Medicare. We provide detailed superbills and medical documentation that patients can submit to their carriers for potential out-of-network reimbursement. Our patient coordinator can discuss costs, payment plans, and documentation options before you schedule.
Can stem cell or exosome therapy help with stroke recovery?+
Early research has shown promising effects on neuroinflammation and neural plasticity. We offer MSC and exosome therapy alongside conventional rehabilitation and discuss the current evidence with every patient.
Read the full answer
Preclinical research has shown effects on neuroinflammation reduction, angiogenesis, and neural plasticity. A Phase 2 trial published in Stroke in 2018 demonstrated safety and preliminary efficacy signals for IV MSC administration in ischemic stroke patients. We offer MSC and exosome therapy under the practice of medicine and discuss the current evidence base with every patient. These are administered alongside conventional rehabilitation.
Do you coordinate with my rehabilitation therapists?+
Yes. We communicate with your physical, occupational, and speech therapists to ensure our neurological treatment complements their work. We can also provide referrals in the Jacksonville area.
Read the full answer
Yes. We communicate with your rehabilitation team to ensure our neurological treatment complements your physical, occupational, and speech therapy schedules. If you do not yet have a rehabilitation team, we can provide referrals in the Jacksonville area.
How do you measure whether brain function is actually improving?+
We use neurocognitive testing, volumetric MRI and DTI imaging at baseline and follow-up. We also track functional outcomes like daily activities, speech, and motor function.
Read the full answer
We track recovery using neurocognitive testing, NeuroQuant volumetric MRI and DTI imaging at baseline and follow-up intervals. Functional outcomes including daily activities, speech fluency, and motor function are also documented. The measurements must show improvement. Subjective impressions alone are not sufficient.
Recovery Doesn’t Have to Plateau
If you or someone you care for has been told that this is as good as it gets after a stroke, that conclusion may reflect the limits of the evaluation, not the limits of the brain. Dr. Orr and the team at The Neurogenesis Project are accepting post-stroke patients in St. Marys, Georgia.